Medartis Holding AG
Medartis Holding AG (MDRSF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Medartis Holding AG (MDRSF), covering cash flow, earnings, and balance sheets.
Medartis Holding AG (MDRSF) Income Statement & Financial Overview
Review Medartis Holding AG MDRSF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $113.30M | $111.53M | $108.76M | $103.25M |
| Cost of Revenue | $24.18M | $21.97M | $20.92M | $23.51M |
| Gross Profit | $89.12M | $89.56M | $87.84M | $79.74M |
| Gross Profit Ratio | $0.79 | $0.80 | $0.81 | $0.77 |
| R&D Expenses | $20.96M | $22.14M | $12.50M | $13.41M |
| SG&A Expenses | $68.82M | $71.69M | $66.70M | $63.53M |
| Operating Expenses | $89.78M | $93.83M | $79.19M | $76.94M |
| Total Costs & Expenses | -$113.96M | $115.80M | $100.11M | $100.46M |
| Interest Income | $0.00 | $2.04M | $148584.00 | $188416.00 |
| Interest Expense | $4.49M | $2.31M | $4.81M | $2.84M |
| Depreciation & Amortization | $11.49M | $10.81M | $10.74M | $10.26M |
| EBITDA | $15.39M | $15.57M | $17.77M | $13.24M |
| EBITDA Ratio | $0.14 | $0.14 | $0.18 | $0.13 |
| Operating Income | -$658000.00 | -$4.27M | $8.64M | $2.80M |
| Operating Income Ratio | -$0.006 | -$0.04 | $0.08 | $0.03 |
| Other Income/Expenses (Net) | $70000.00 | $6.72M | -$6.42M | -$2.65M |
| Income Before Tax | -$588000.00 | $2.45M | $2.22M | $145405.00 |
| Income Before Tax Ratio | -$0.005 | $0.02 | $0.02 | $0.001 |
| Income Tax Expense | -$1.65M | $625000.00 | $182052.00 | $992948.00 |
| Net Income | $963000.00 | $2.56M | $1.47M | -$848041.00 |
| Net Income Ratio | $0.008 | $0.02 | $0.01 | -$0.008 |
| EPS | $0.08 | $0.19 | $0.12 | -$0.07 |
| Diluted EPS | $0.08 | $0.19 | $0.12 | -$0.07 |
| Weighted Avg Shares Outstanding | $12.40M | $13.50M | $12.36M | $12.11M |
| Weighted Avg Shares Outstanding (Diluted) | $12.40M | $13.50M | $12.36M | $12.11M |
The company's financials show resilient growth, with revenue advancing from $103.25M in Q2 2023 to $113.30M in Q4 2024. Gross profit remained healthy with margins at 79% in Q4 2024 compared to 77% in Q2 2023. Operating income hit -$658000.00 last quarter, sustaining a consistent -1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $15.39M. Net income dropped to $963000.00, while earnings per share reached $0.08. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan